PT - JOURNAL ARTICLE AU - Abraham Nunes AU - William Stone AU - Raffaella Ardau AU - Anne Berghöfer AU - Alberto Bocchetta AU - Caterina Chillotti AU - Valeria Deiana AU - Franziska Degenhardt AU - Andreas J. Forstner AU - Julie S. Menzies AU - Eva Grof AU - Tomas Hajek AU - Mirko Manchia AU - Francis McMahon AU - Bruno Müller-Oerlinghausen AU - Markus M. Nöthen AU - Marco Pinna AU - Claudia Pisanu AU - Claire O’Donovan AU - Marcella D.C. Rietschel AU - Guy Rouleau AU - Thomas Schulze AU - Giovanni Severino AU - Claire M Slaney AU - Alessio Squassina AU - Aleksandra Suwalska AU - Gustavo Turecki AU - Petr Zvolsky AU - Pablo Cervantes AU - Maria del Zompo AU - Paul Grof AU - Janusz Rybakowski AU - Leonardo Tondo AU - Thomas Trappenberg AU - Martin Alda TI - Exemplar Scoring Identifies Genetically Separable Phenotypes of Lithium Responsive Bipolar Disorder AID - 10.1101/2020.05.19.20098566 DP - 2020 Jan 01 TA - medRxiv PG - 2020.05.19.20098566 4099 - http://medrxiv.org/content/early/2020/05/22/2020.05.19.20098566.short 4100 - http://medrxiv.org/content/early/2020/05/22/2020.05.19.20098566.full AB - Predicting lithium response (LiR) in bipolar disorder (BD) could expedite effective pharmacotherapy, but phenotypic heterogeneity of bipolar disorder has complicated the search for genomic markers. We thus sought to determine whether patients with “exemplary phenotypes”—those whose clinical features are reliably predictive of LiR and non-response (LiNR)—are more genetically separable than those with less exemplary phenotypes. We applied machine learning methods to clinical data collected from people with BD (n=1266 across 7 international centres; 34.7% responders) to compute an “exemplar score,” which identified a subset of subjects whose clinical phenotypes were most robustly predictive of LiR/LiNR. For subjects whose genotypes were available (n=321), we evaluated whether responders/non-responders with exemplary phenotypes could be more accurately classified based on genetic data than those with non-exemplary phenotypes. We showed that the best LiR exemplars had later illness onset, completely episodic clinical course, absence of rapid cycling and psychosis, and few psychiatric comorbidities. The best exemplars of LiR and LiNR were genetically separable with an area under the receiver operating characteristic curve of 0.88 (IQR [0.83, 0.98]), compared to 0.66 [0.61, 0.80] (p=0.0032) among the poor exemplars. Variants in the Alzheimer’s amyloid secretase pathway, along with G-protein coupled receptor, muscarinic acetylcholine, and histamine H1R signaling pathways were particularly informative predictors. In sum, the most reliably predictive clinical features of LiR and LiNR patients correspond to previously well-characterized phenotypic spectra whose genomic profiles are relatively distinct. Future work must enlarge the sample for genomic classification and include prediction of response to other mood stabilizers.Competing Interest StatementThe authors have declared no competing interest.Funding StatementGenome Canada (MA, AN), Dalhousie Department of Psychiatry Research Fund (MA, AN), Dalhousie Medical Research Foundation and the Lindsay Family (MA, AN), Canadian Institutes of Health Research #418254 (MA, AN), Nova Scotia Health Research Foundation Scotia Scholars Graduate Scholarship (AN), Killam Postgraduate Scholarship (AN), EMBED-BMBF-01EW1904 (MDCR).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData requests may be provided to the authors.